Drugs / platelet-rich plasma extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02993809 | Mar 2018 → Dec 2019 | limb ischemia, peripheral vascular disease, ulcer of lower limbs | South China Research Center for Stem Cell and Regenerative Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platelet-rich plasma extract | “platelet-rich plasma extract (PRPE)” NCT02993809 ↗ |
| Known as | PRPE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02993809 ↗ |